Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 50

Results For "therapy"

2230 News Found

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi
Hospitals | May 01, 2026

Fortis Cancer Summit 2026 to unite global oncology leaders in New Delhi

The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries


Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Biopharma | May 01, 2026

Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%

Strong CDMO growth, improved product mix and operational leverage drive profitability expansion


JP Nadda highlights India’s push for APIs, biologics and translational research
Policy | May 01, 2026

JP Nadda highlights India’s push for APIs, biologics and translational research

On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push
News | April 30, 2026

GSK wins regulatory boost for once-monthly liver drug efimosfermin in MASH push

The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need


Pfizer drug delivers breakthrough in late-stage blood cancer trial
Clinical Trials | April 30, 2026

Pfizer drug delivers breakthrough in late-stage blood cancer trial

Patients receiving ELREXFIO largely remained free from disease progression during the interim analysis


Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
News | April 30, 2026

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

The agreement could rise to $900 million if key commercial milestones are met


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation
Policy | April 30, 2026

JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation

Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice


Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy
Biopharma | April 29, 2026

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights